Tech giants like IBM and Google have invested billions internally in A.I. research, but the past few years have also seen a wave of acquisitions, as big companies buy up startups to obtain top talent and new data-crunching science. (Acquisition figures are since 2010. source: CB Insights)
ALPHABET
(14 ACQUISITIONS)
> Google CEO Sundar Pichai has made the case that artificial intelligence is core to the search giant’s major businesses. It definitely shows in its acquisitions, including its 2014 purchase for over $600 million of U.K.–based Deep-Mind—whose software is best known for being the first to defeat a human champion at the strategy game Go (above).
APPLE
(13 ACQUISITIONS)
> Apple kicked off its A.I. acquisition spree in 2010 when it bought Siri, whose voice-recognition interface has since become, for many, the embodiment of consumer-facing A.I.
(6 ACQUISITIONS)
> The social networking giant is also an A.I. heavyweight, using deep learning to clean up its News Feed (though that’s very much a work in progress). Its recent big buys include the 2017 acquisition of Ozlo to improve its messaging app.
AMAZON
(5 ACQUISITIONS)
> It takes a lot of A.I. to fuel both its online retail (matching products to customer preferences) and its cloud-computing business. Amazon also uses A.I. to help screen the produce it ships through its grocery delivery business.
Image Credit: Go Fans watch a TV screen showing the live broadcast of the Google DeepMind Challenge Match in Seoul, South Korea. Google’s artificial intelligence program AlphaGo beat top-class South Korean Go player Lee Se-dol. Seung Il Ryu—Zuma Wire
News This Week
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Leave A Comment